The Form 4 filing, an SEC report of insider stock activity, was filed on November 18, 2026. It reports a November 16 sale by Kenneth A. Burdick, a director of LifeStance Health Group (LFST).
The company is listed in the healthcare sector and the medical care facilities industry.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-16 |
| Date of Latest Transaction | 2026-11-16 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 124,228 |
| Price | $14.31 |
| Total Transaction Value | $1,777,702.68 |
| Insider | |
| Ticker Symbol | LFST |
| Company | LifeStance Health Group, Inc. |
| Insider Name | Burdick Kenneth A |
| Insider Title | Director |
| Sector - Industry | Healthcare - Medical Care Facilities |
| Holdings | |
| Total Shares Owned After Transaction | 3,472,038 |
| Position Size Change | 3.45% |
| Filing | |
| Filing Date | 2026-11-18 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a share sale, reported under transaction code S. Kenneth A. Burdick sold 124,228 shares in one transaction.
What was the average price of the transaction?
The reported average price was $14.31 per share. That price applies to the single sale made on November 16.
How did this transaction affect the insider's holdings?
He sold 124,228 shares and reported 3,472,038 shares owned afterward. The sale was 3.45% of the shares he held before the trade. Adding the shares sold to the reported remaining balance gives 3,596,266 shares before the sale.
What's the total transaction value?
The total transaction value was $1,777,702.68. That is the reported value of the single sale, covering all 124,228 shares sold.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement for this sale. Footnote text was not provided for this report, so any further terms or explanations remain unknown.
For research purposes only; not investment advice.